LYC Healthcare Berhad (KLSE:LYC)
Malaysia · Delayed Price · Currency is MYR 0.0150
+0.0050 (50.00%)
At close: Sep 21, 2026
LYC Healthcare Berhad Financials Overview
Financials in millions MYR. Fiscal year is April - March.
Millions MYR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 137.05 | 135.08 | 155.52 | 128.99 | 92.28 | 64.6 |
Revenue Growth | -7.53% | -13.15% | 20.57% | 39.78% | 42.86% | 144.56% |
Gross Profit Gross Profit Growth | 49.49 | 52.93 | 68.97 | 68.27 | 41.58 | 32.19 |
Operating Income Operating Income Growth | -0.38 | -1.44 | 2 | -7.68 | 1.57 | 7.64 |
Net Income Net Income Growth | -21.57 | -22.94 | -17.07 | -20.78 | -19.19 | -9.23 |
Earnings Per Share EPS Growth | -0.03 | -0.03 | -0.02 | -0.03 | -0.03 | -0.02 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Healthcare Services Healthcare Services Growth | 136.83 | 134.7 | 153.14 | 129.3 | 89.4 | 60.98 |
Elimination Elimination Growth | -2.58 | -2.8 | -8.02 | -8.41 | -3.18 | -1 |
Computing and Electronic Services Computing and Electronic Services Growth | - | 0.39 | 2.84 | 3.05 | 3.81 | 4.61 |
Others Others Growth | 2.68 | 2.79 | 7.56 | 5.04 | 2.25 | 0 |
Total Total Growth | 137.05 | 135.08 | 155.52 | 128.99 | 92.28 | 64.6 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 17.37 | 9.07 | 8.96 | 16.91 | 40.75 | 22.12 |
Total Debt Total Debt Growth | 101.6 | 106.83 | 138.19 | 138.15 | 115.22 | 124.04 |
Net Cash (Debt) Net Cash Growth | -84.24 | -97.76 | -129.23 | -121.23 | -74.47 | -101.93 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.11 | -0.13 | -0.18 | -0.17 | -0.14 | -0.23 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 20.73 | 28.47 | 28.39 | 10.74 | 4.99 | 0.34 |
Capital Expenditures CapEx Growth | -3 | -2 | -5.65 | -5.7 | -2.53 | -2.88 |
Free Cash Flow Free Cash Flow Growth | 17.72 | 26.47 | 22.74 | 5.03 | 2.46 | -2.54 |
Free Cash Flow Growth | -56.37% | 16.40% | 351.86% | 104.68% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 36.11% | 39.19% | 44.35% | 52.92% | 45.06% | 49.83% |
Operating Margin | -0.27% | -1.06% | 1.28% | -5.96% | 1.70% | 11.83% |
Pretax Margin | -5.00% | -6.54% | -5.20% | -9.96% | -12.86% | -1.89% |
Profit Margin | -15.74% | -16.98% | -10.97% | -16.11% | -20.79% | -14.28% |
FCF Margin | 12.93% | 19.60% | 14.62% | 3.90% | 2.67% | -3.93% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Forward PE | - | 16.50 | 16.50 | 16.50 | 16.50 | 16.50 |
P/FCF Ratio | 0.42 | 0.42 | 2.04 | 26.28 | 68.72 | - |
PS Ratio | 0.05 | 0.08 | 0.30 | 1.02 | 1.83 | 1.76 |